Hyperthermia promotes apoptosis and suppresses invasion in C6 rat glioma cells

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 7, 2012, Pages 3239-3245

  Wang, Dong Chun ^a   Zhang, Yan ^b   Chen, Hai Yan ^c   Li, Xiao Li ^d   Qin, Li Juan ^e   Li, Ya Juan ^d   Zhang, Hong Yi ^d   Wang, Shuo ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d HEBEI UNITED UNIVERSITY   (China)

^e Tangshan Workers Hospital   (China)

Author keywords

Glioma invasiveness; Hyperthermia; NF B; P38 MAPK; TNF

Indexed keywords

EID: 84873572743     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.7.3239     Document Type: Article

References (55)

1. Ashkenazi A, Pai RC, Fong S, et al. (1999). Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest, 104, 155-62.
2. Baud V, Karin M. (2001). Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol, 11, 372-7.
3. Beg AA, Baltimore D. (1996). An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science, 274, 782-4.
4. de Vera ME, Wong JM, Zhou JY, et al. (1996). Cytokine-induced nitric oxide synthase gene transcription is blocked by the heat shock response in human liver cells. Surgery, 120, 144-9.
5. Dorsett Y, Tuschl T. (2004). siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov, 3, 318-29.
6. Feinstein DL, Galea E, Aquino DA, et al. (1996). Heat shock protein 70 suppresses astroglial-inducible nitric-oxide synthase expression by decreasing NFkappaB activation. J Biol Chem, 271, 17724-32.
7. Fiorentini G, Giovanis P, Rossi S, et al. (2006). A phase II clinical study on relapsed malignant gliomas treated with electrohyperthermia. In Vivo, 20, 721-4.
8. Flanagan SW, Moseley PL, Buettner GR. (1998). Increased flux of free radicals in cells subjected to hyperthermia: detection by electron paramagnetic resonance spin trapping. FEBS Lett, 431, 285-6.
9. Frank J, Kelleher DK, Pompella A, et al. (1998). Enhancement of oxidative cell injury and antitumor effects of localized 44°C hyperthermia upon combination with respiratory hyperoxia and xanthine oxidase. Cancer Res, 58, 2693-8.
10. Gong XM, Choi J, Franzin CM, et al. (2004). Conformation of membrane-associated proapoptotic tBid. J Biol Chem, 279, 28954-60.
11. Hagemann T, Wilson J, Kulbe H, et al. (2005). Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol, 175, 1197-205.
12. Hall DM, Buettner GR, Matthes RD, Gisolfi CV. (1994). Hyperthermia stimulates nitric oxide formation: electron paramagnetic resonance detection of NO-heme in blood. J Appl Physiol, 77, 548-53.
13. Haveman J, Sminia P, Wondergem J, van der Zee J, Hulshof MC. (2005). Effects of hyperthermia on the central nervous system: what was learnt from animal studies? Int J Hyperthermia, 21, 473-87.
14. Hayden MS, Ghosh S. Signaling to NF-κB. (2004). Genes Dev, 18, 2195-24.
15. Kato S, Sadarangani A, Lange S et al. (2007). The oestrogen metabolite 2-methoxyoestradiol alone or in combination with tumour necrosis factor-related apoptosis-inducing ligand mediates apoptosis in cancerous but not healthy cells of the human endometrium. Endocr Relat Cancer, 14, 351-68.
16. Kischkel FC, Lawrence DA, Chuntharapai A, et al. (2000). Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity, 12, 611-20.
17. Kokura S, Yoshida N, Ueda M, et al. (2003). Hyperthermia enhances tumor necrosis factor alpha-induced apoptosis of a human gastric cancer cell line. Cancer Lett, 201, 89-96.
18. Kulbe H, Hagemann T, Szlosarek PW, Balkwill FR, Wilson JL (2005). The inflammatory cytokine tumor necrosis factoralpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res, 65, 10355-62.
19. Lee YJ, Hou Z, Curetty L, Cho JM, Corry PM. (1993). Synergistic effects of cytokine and hyperthermia oncytotoxicity in HT-29 cells are not mediated by alteration of induced protein levels. J Cell Physiol, 155, 27-35.
20. Li P, Nijhawan D, Budihardjo I, et al. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91, 479-89.
21. Li Q, Verma IM. (2002). NF_B regulation in the immune system. Nat Rev Immunol, 2, 725-34.
22. Liu ZG, Hsu H, Goeddel DV, Karin M. (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell, 87, 565-76.
23. McCoy MK, Tansey MG. (2008). TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation, 5, 45.
24. Montesano R, Soulie P, Eble JA, Carrozzino F. (2005). Tumour necrosis factor alpha confers an invasive, transformed phenotype on mammary epithelial cells. J Cell Sci, 118, 3487-500.
25. Moran CJ, Marchosky JA, Wippold FJ, DeFord JA, Fearnot NE. (1995). Conductive interstitial hyperthermia in the treatment of intracranial metastatic disease. J Neurooncol, 26, 53-63.
26. Oh KJ, Barbuto S, Meyer N, et al. (2005). Conformational changes in BID, a pro-apoptotic BCL-2 family member, upon membrane binding. A site-directed spin labeling study. J Biol Chem, 280, 753-67.
27. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, et al. (1995). Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet, 345, 540-3.
28. Park SM, Schickel R, Peter ME. (2005). Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Biol, 17, 610-6.
29. Ryu J, Ku BM, Lee YK, et al. (2011). Resveratrol reduces TNF-α-induced U373MG human glioma cell invasion through regulating NF-κB activation and uPA/uPAR expression. Anticancer Res, 31, 4223-30.
30. Shen H-M, Pervaiz S. (2006). TNF receptor superfamily-induced cell death: redoxdependent execution. FASEB J, 20, 1589-98.
31. Silva AC, Oliveira TR, Mamani JB et al. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int J Nanomedicine, 6, 591-603.
32. Skibba JL, Powers RH, Stadnicka A, Kalbfleisch JH. (1990). Lipid peroxidation caused by hyperthermic perfusion of rat liver. Biochem Pharmacol, 40, 1411-4.
33. Sminia P, Van der Zee J, Wondergem J, Haveman J. (1994). Effect of hyperthermia on the central nervous system: a review. Int J Hyperthermia, 10, 1-30.
34. Sneed PK, Stauffer PR, Gutin PH, et al. (1991). Interstitial irradiation and hyperthermia for the treatment of recurrent malignant brain tumors. Neurosurgery, 28, 206-15.
35. Sneed PK, Gutin PH, Stauffer PR, et al. (1992). Thermoradiotherapy of recurrent malignant brain tumors. Int J Radiat Oncol Biol Phys, 23, 853-61.
36. Sneed PK, Stauffer PR, McDermott MW, et al. (1998). Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/-hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys, 40, 287-95.
37. Stea B, Cetas TC, Cassady JR, et al. (1990). Interstitial thermoradiotherapy of brain tumors: preliminary results of a phase I clinical trial. Int J Radiat Oncol Biol Phys, 19, 1463-71.
38. Stea B, Rossman K, Kittelson J, et al. (1994). Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis. Int J Radiat Oncol Biol Phys, 30, 591-600.
39. Stupp R, Hegi ME, Gilbert MR, Chakravarti A. (2007). Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol, 25, 4127-36.
40. Stupp R, Mason WP, van den Bent MJ, et al. (2005). Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 352, 987-96.
41. Tanaka R, Kim CH, Yamada N, Saito Y. (1987). Radiofrequency hyperthermia for malignant brain tumors: preliminary results of clinical trials. Neurosurgery, 21, 478-83.
42. Thomas LR, Henson A, Reed JC, Salsbury FR, Thorburn A. (2004). Direct binding of Fas-associated death domain (FADD) to the tumor necrosis factor-related apoptosisinducing ligand receptor DR5 is regulated by the death effector domain of FADD. J Biol Chem, 279, 32780-5.
43. Tulapurkar ME, Asiegbu BE, Singh IS, Hasday JD. (2009). Hyperthermia in the febrile range induces HSP72 expression proportional to exposure temperature but not to HSF-1 DNAbinding activity in human lung epithelial A549 cells. Cell Stress Chaperones, 14, 499-508.
44. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM. (1996). Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science, 274, 787-9.
45. Van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, et al. (2000). Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet, 355, 1119-25.
46. Venkataraman S, Wagner BA, Jiang X, et al. (2004). Overexpression of manganese superoxide dismutase promotes the survival of prostate cancer cells exposed to hyperthermia. Free Radic Res, 38, 1119-32.
47. Vernon CC, Hand JW, Field SB, et al. (1996). Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys, 35, 731-44.
48. Walczak H, Miller RE, Ariail K, et al. (1999). Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med, 5, 157-163.
49. Wang CY, Mayo MW, Baldwin AS. (1996). Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science, 274, 784-787.
50. Wong HR, Ryan M, Gebb S, Wispe JR. (1997). Selective and transient in vitro effects of heat shock on alveolar type II cell gene expression. Am J Physiol, 272, L132-8.
51. Yamaguchi S, Tanabe K, Takai S, et al. (2009). Involvement of Rho-kinase in tumor necrosis factor-ainduced interleukin-6 release from C6 glioma cells. Nerochem Int, 55, 438-45.
52. Yoo J, Lee Y. (2007). Effect of hyperthermia on TRAIL-induced apoptotic death in human colon cancer cells: development of a novel strategy for regional therapy. J Cell Biochem, 101, 619-30.
53. Yoo L, Lee Y. (2008). Effect of hyperthermia and chemotherapeutic agents on TRAIL-induced cell death in human colon cancer cells. J Cell Biochem, 103, 98-109.
54. Zhang B-C, Li Q, Ye J. (2004). Role of p38MAKP in mediating TNF-induced apoptosis of rat glioma cell line C6. Journal of Medical Colleges of PLA, 18, 308-11.
55. Zhang X, Chen T, Zhang J, et al. (2012). Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation. Cancer Sci, 103, 181-90.